hotspot -WSS

hotspot

author：focus 2025-09-28 11:56:24 - browse：9421

Obesity conference attendees with a pink and blue Wegovy sign hanging from the ceiling above. -- obesity coverage from STAT — Wegovy, the obesity drug, was inescapable at the ObesityWeek conference in Dallas. Elaine Chen

DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

explore

WSS

Reframing the conversation around gain

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Biden White House, tech companies launch new safeguards around emerging AI technology

What is the Turing Test that determines if computers can think?

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Creating egg and sperm cells from stem cells raises ethical issues

focus

hotspot

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

U.K. researchers warn about biases in medical devices, algorithms

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why the advice to take all your antibiotics may be wrong

Moonlake's readout produced a cash windfall. Risks remain

Leading voice in opioid treatment defends methadone clinic system

BioMarin wins approval for gene therapy to treat hemophilia A

New chart reveals military’s vast involvement in Operation Warp Speed

At least 13 dead in Texas as scorching temps continue

A former Republican legislative candidate has been charged for his role in the US Capitol riot

knowledge

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

What is the Turing Test that determines if computers can think?

Prosecutors say FTX founder Sam Bankman

Leading voice in opioid treatment defends methadone clinic system

Hey, doctors: Don't be no

Methadone treatment changes are coming. Do they go far enough?

explore

explore

knowledge

focus